
TCR2 Therapeutics (TCRR) Book Value
Market Cap: $58.11M
Avg Volume: 325.04K
Industry: Biotechnology
Sector: Healthcare
What is TCR2 Therapeutics's Book Value?
- TCR2 Therapeutics's annual Book Value is $140.86M.
- TCR2 Therapeutics's quarterly Book Value is $101.33M.
What is Book Value?
Book Value represents the total value of a company's assets that shareholders would theoretically receive if a company were liquidated. It is calculated as the total assets minus intangible assets and total liabilities.
How is Book Value calculated?
Book Value is calculated using the following formula:
Book Value = Total Assets - Intangible Assets - Total Liabilities
Related Metrics
Other important metrics to assess TCR2 Therapeutics's financial health include:
- Book Value per Share - measures the per-share value of a company based on its equity:
- Annual: $3.65
- Quarterly: $2.58
- Tangible Book Value per Share - measures the per-share value of a company's tangible assets:
- Annual: $3.65
- Quarterly: $2.58
These metrics provide insights into TCR2 Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Book Value
$140.86M
Quarterly Book Value
$101.33M
TCR2 Therapeutics Historical Book Value
Historical Book Value per Share
Historical Tangible Book Value per Share
TCR2 Therapeutics Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2022.
Year | Book Value | Book Value Change | Book Value per Share | Tangible Book Value per Share |
---|---|---|---|---|
2022 | $140.86M | -49.96% | 3.65 | 3.65 |
2021 | $281.48M | 18.99% | 7.42 | 7.42 |
2020 | $236.55M | 47.43% | 8.45 | 8.45 |
2019 | $160.45M | -287.23% | 7.60 | 7.60 |
2018 | $-85.70M | 225.54% | -3.70 | -3.70 |
2017 | $-26.32M | 121.51% | -5.13 | -5.13 |
2016 | $-11.88M | N/A | -2.32 | -2.32 |
Related Metrics
Explore detailed financial metrics and analysis for TCRR.